Real-world Use Patterns, Effectiveness, and Tolerability of Sacituzumab Govitecan for Second-Line and Later-Line Treatment of Metastatic Triple-Negative Breast Cancer in the United States.
Breast Cancer Research and Treatment(2024)
Key words
Sacituzumab govitecan,Triple-negative breast cancer,Real-world clinical outcomes,Second-line,Metastatic,Treatment patterns
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined